Ardent Health Partners Overview
Ardent Health Partners Target Price
See Ardent Health Partners's analyst price targets ($14) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.91
Average Target Price
$13.50
23.7% upside
23.7% upside2 analysts in the last 4 months
High: $14 | Low: $13
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-06 | Goldman Sachs | $13 | 19.2% upside |  |
| 2026-08-06 | GuggenheimJason Cassorla | $14 | 28.3% upside | |
| 2026-03-09 | RBC CapitalBen Hendrix | $13 | 19.2% upside | |
| 2025-12-18 | UBS | $14 | 28.3% upside | |
| 2025-12-18 | Mizuho SecuritiesAnn Hynes | $12 | 10% upside | |
| 2025-11-18 | Mizuho Securities | $13 | 19.2% upside | |
| 2025-11-14 | Leerink PartnersWhit Mayo | $16 | 46.7% upside | |
| 2025-11-14 | Truist Financial | $13 | 19.2% upside | |
| 2025-11-14 | RBC CapitalBen Hendrix | $16 | 46.7% upside | |
| 2025-11-14 | Morgan Stanley | $12 | 10% upside | |
| 2025-10-14 | Goldman Sachs | $19 | 74.2% upside | |
| 2025-09-10 | UBS | $17 | 55.8% upside | |
| 2025-03-04 | RBC Capital | $21 | 92.5% upside | |
| 2024-10-10 | KeyBancMatthew Gillmor | $24 | 120% upside | |
| 2024-09-19 | StephensScott Fidel | $24 | 120% upside | |
| 2024-08-16 | Loop Capital MarketsTimothy Greaves | $21 | 92.5% upside | |
| 2024-08-16 | Truist FinancialDavid MacDonald | $22 | 101.6% upside | |
| 2024-08-12 | Truist FinancialDavid MacDonald | $21 | 92.5% upside | |
| 2024-08-12 | Mizuho SecuritiesAnn Hynes | $20 | 83.3% upside | |
| 2024-08-12 | Morgan StanleyCraig Hettenbach | $27 | 147.5% upside | |